US EditionHealth expands access to medication for patients with sickle cell disease
Summary by EBC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Health expands access to medication for patients with sickle cell disease
The Ministry of Health announced this Thursday (3) that it will incorporate the drug deferiprone to the treatment of iron overload in patients with sickle cell disease in the Unified Health System (SUS). In a note, the portfolio highlighted that, with the incorporation, anyone who needs treatment for excessive iron accumulation in the body, regardless of the cause, will have access to all therapeutic alternatives available in the public network.…
·Quadra, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
